AI assistant
Sending…
ENDRA Life Sciences Inc. — Director's Dealing 2018
Apr 19, 2018
35444_dirs_2018-04-19_9ba44e39-bbd9-4364-a1ef-1b410d38bb1b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2017-05-09
Reporting Person: Longboard Capital Advisors, LLC (10% Owner)
Reporting Person: Conrad Brett (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.0001 par value | 218899 | Indirect |
| Common Stock, $0.0001 par value | 210538 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $20.03 | 2020-05-29 | Common Stock (12488) | Indirect | |
| Warrants | $6.25 | 2022-05-12 | Common Stock (210538) | Indirect |
Footnotes
F1: Longboard Capital Advisors, LLC is the General Partner of Blue Earth Fund, LP. Blue Earth Fund, LP owns 218,899 shares of Common Stock and 12,488 Warrants to purchase Common Stock in ENDRA Life Sciences, Inc.
F2: Longboard Capital Advisors, LLC is the Investment Manager of Grayboard Investments, Ltd. Grayboard Investments, Ltd. owns 210,538 shares of Common Stock and 210,538 Warrants to purchase Common Stock in ENDRA Life Sciences, Inc.
More from ENDRA Life Sciences Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23